Since the discovery of c-MET in the 1980s, the c-MET pathway has gained considerable interest related to a variety of cancers due to the diversity of the cellular responses that follow c-MET activation, including cell growth, survival, motility, invasion, and metastasis [8]. The gene discussed is MET; the disease is cancer.